Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
about
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approachesBacteria and cancer: cause, coincidence or cure? A reviewImmunotherapy in non-small cell lung cancer: the clinical impact of immune response and targetingImmunotherapy for lung cancer: advances and prospectsTargeted drugs in small-cell lung cancerSmall cell lung cancer (SCLC): no treatment advances in recent yearsCancer stem cells in small cell lung cancerCellular and molecular biology of small cell lung cancer: an overviewCancer stem cells and immunoresistance: clinical implications and solutionsNovel therapies in small cell lung cancerTherapeutic vaccines in non-small cell lung cancerAdvances of immunotherapy in small cell lung cancerRacotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataThe Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.The Humanistic Burden of Small Cell Lung Cancer (SCLC): A Systematic Review of Health-Related Quality of Life (HRQoL) Literature.Fast, hungry and unstable: finding the Achilles' heel of small-cell lung cancer.Immunotherapy for metastatic solid cancersImmunotherapy for lung cancers.Therapeutic cancer vaccines: are we there yet?Targeted therapies in small cell lung cancer: a reviewCancer vaccines and carbohydrate epitopes.Chemotherapy for small cell lung cancer: a comprehensive reviewImmune microenvironments in solid tumors: new targets for therapy.Current status of immunotherapy for the treatment of lung cancer.Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer VaccinesSmall cell lung cancer: will recent progress lead to improved outcomes?Immunotherapy treatments for small-cell lung cancer: past, present and future.Novel therapeutic approaches for small cell lung cancer: the future has arrivedMolecular identification of GD3 as a suppressor of the innate immune response in ovarian cancerImmunotherapy of cancer in 2012.Lung cancer: Biology and treatment options.Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulinsAnti-ganglioside anti-idiotypic vaccination: more than molecular mimicry.Targeted therapies in small cell lung cancerRole of monoclonal antibodies in tumor-specific immunity.Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?Novel compounds in the treatment of lung cancer: current and developing therapeutic agents.Targeted therapies in small-cell lung cancer.The role of the immune response in merkel cell carcinoma.Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci.
P2860
Q21129299-D7D61F25-3E9F-402C-B4F2-2F2DF7B6CB12Q21245476-DBCE92D2-C565-4973-A8BF-6E61FCC9D36DQ26738673-055A38E9-B09F-4BFA-BBDC-FF4993FFAAFAQ26750617-3338E491-E9AA-4A55-9347-DFC1D7621571Q26767017-BF6EE8B2-F4DF-4698-AE98-67F101089CDEQ26767020-7D21A175-8A46-4F57-AA87-C44C47A168C6Q26767026-4E328F15-B62F-4A1D-B7F6-A8E82FF8D51AQ26767029-76C8604F-634A-40B0-8921-D837998011DBQ26769757-53EA7A9A-198D-4FAC-9308-A057B27347C7Q26775390-1DBC08F2-CB37-4575-AA33-37D7FE270739Q26864896-47372F54-0B4F-4089-B1FC-9EF672D0C35BQ27027662-42CEA803-C698-4350-AF19-1C3EE1037C05Q30575331-4BEF5912-0388-4699-B0B3-3BF665EFD80BQ31034367-0EB01C4A-8648-4B4D-AFE3-2745AC9C5A71Q33799729-F1436F29-7E37-4A63-9DC9-80B2502BB385Q34013850-48244D24-0B66-4AEB-8728-3F451DC22B69Q34219970-AD0D9A68-DAAC-45C9-A10A-ACD5BEF6B11EQ34557611-10592641-26D4-4B32-AF14-3CE0A5FCF030Q34786691-99ECD982-4CDE-4363-9CD3-9F3A868E6647Q35076234-D9BB9C73-0555-4CC9-BED0-1CACF55F48C7Q35525289-4A2CA3A7-8891-46BE-ABA6-643FB4782929Q35569379-4357B920-D128-4762-B355-497D56C0F228Q35642044-F4ACB422-E6D7-4EAC-B2BC-E74B167039D3Q35667739-E363B168-78AA-4943-89EB-B65599BFC95DQ35774908-928AD55E-D055-4761-BD76-28333CE66769Q35836257-E53CBEA1-787E-419B-93CC-8A6074620F41Q35904003-25683E13-30A4-4C80-B222-7D56F8777087Q36084288-E1FC87DA-2C2D-4B16-BD5C-28777094FD10Q36224039-CAE71D43-8A65-4F06-8AC0-70E9AE10FE90Q36243536-BEFA34C4-4D39-47CD-BB2C-A002C591E820Q36328370-5A214CF9-47AD-460F-9D0E-52B3A97D3C19Q36386109-53B7E322-0641-40BE-A7D7-CB52F196D7AAQ36410563-6C04A80D-E956-4178-8185-C5C98C8E51C4Q36475811-9FC18E86-5341-445A-A92C-330520D7EBDCQ36739762-97BF8C85-AD94-4F5C-B96A-B50BE0911494Q36811784-9ACC104F-50CB-4BC5-BAA1-17C69472C792Q36890658-00F7F048-4E68-4F89-8EEB-AA5D45070171Q36897340-D410534A-74C9-428B-9DD6-08187A55967BQ37061729-206492D6-56A7-4666-8FAE-C65ADA338E59Q37066964-8CFCACE9-0A23-4831-8607-BB4FF9E82628
P2860
Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase III study of adjuvant va ...... er 08971-08971B; Silva Study).
@ast
Phase III study of adjuvant va ...... er 08971-08971B; Silva Study).
@en
Phase III study of adjuvant va ...... disease small-cell lung cancer
@nl
type
label
Phase III study of adjuvant va ...... er 08971-08971B; Silva Study).
@ast
Phase III study of adjuvant va ...... er 08971-08971B; Silva Study).
@en
Phase III study of adjuvant va ...... disease small-cell lung cancer
@nl
prefLabel
Phase III study of adjuvant va ...... er 08971-08971B; Silva Study).
@ast
Phase III study of adjuvant va ...... er 08971-08971B; Silva Study).
@en
Phase III study of adjuvant va ...... disease small-cell lung cancer
@nl
P2093
P356
P1476
Phase III study of adjuvant va ...... er 08971-08971B; Silva Study).
@en
P2093
Catherine Legrand
Channa Debruyne
Corneel Coens
Giannicola D'addario
Lisa S Rome
Luc Thiberville
Michael Millward
Oriol Masso
Paul B Chapman
Petr Zatloukal
P304
P356
10.1200/JCO.2005.17.186
P407
P577
2005-10-01T00:00:00Z